Ignite Creation Date:
2024-05-06 @ 7:41 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06096909
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-24
First Post:
2023-09-28
Brief Title:
Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
Sponsor:
China National Center for Cardiovascular Diseases
Organization:
China National Center for Cardiovascular Diseases
Organization Data
Organization:
China National Center for Cardiovascular Diseases
Class:
OTHER_GOV
Study ID:
2021-CXGC03-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
China National Center for Cardiovascular Diseases
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Innovent Biologics Inc | OTHER |